Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
glp-1 research peptides Peptide Research — Semaglutide Tirzepatide MyGLP1Store Eli Lilly just announced hero Variety:Subscription
Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28%
Maximum exposure (Cmax) was unchanged
hero
Variety:Subscription
These drugs have been approved for the treatment of type 2 diabetes and obesity
US$ 28.59
US$ 22.08
US$ 22.53
US$ 24.51
US$ 26.40
